Business Segments · Total Assets
Innovative Medicine — Total Assets
Johnson & Johnson Innovative Medicine — Total Assets increased by 0.1% to $78.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.0%, from $58.73B to $78.12B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ1 2026Apr 22, 2026
Rolls up toTotal Assets
How to read this metric
An increase indicates capital expansion or investment in the segment, while a decrease may suggest divestitures or asset depreciation.
Detailed definition
This represents the total book value of assets specifically allocated to or utilized by the Innovative Medicine segment....
Peer comparison
Standard segment asset reporting required for segment-level financial analysis in large diversified firms.
Metric ID:
jnj_segment_innovative_medicine_assetsHistorical Data
8 periods
| Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $58.44B | $58.32B | $57.07B | $58.73B | $75.49B | $74.42B | $78.06B | $78.12B |
| QoQ Change | — | -0.2% | -2.2% | +2.9% | +28.5% | -1.4% | +4.9% | +0.1% |
| YoY Change | — | -0.2% | -2.2% | — | — | — | +36.8% | +33.0% |
Range$57.07B – $78.12B
CAGR+18.0%
Avg YoY Growth+16.9%
Median YoY Growth+16.4%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's innovative medicine — total assets?
- Johnson & Johnson (JNJ) reported innovative medicine — total assets of $78.12B in Q1 2026.
- How has Johnson & Johnson's innovative medicine — total assets changed year-over-year?
- Johnson & Johnson's innovative medicine — total assets increased by 33.0% year-over-year, from $58.73B to $78.12B.
- What does innovative medicine — total assets mean?
- The total value of all assets, such as equipment and intellectual property, held by the pharmaceutical segment.